Precise prostate cancer diagnosis using fluorescent nanoprobes for detecting PSA and PSMA in serum-Reference-Cited by-同舟云学术

Precise prostate cancer diagnosis using fluorescent nanoprobes for detecting PSA and PSMA in serum

Published:2024 Issue:39 Volume:60 Page:5181-5184
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

Ouyang Mingyi¹,Jia Ming²,Chang Zixuan¹,Wang Yinian¹,Wang Keyi¹,Gao Xiaonan¹^ORCID,Tang Bo¹³^ORCID

Affiliation:

1. College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Provincial Key Laboratory of Clean Production of Fine Chemicals, Shandong Normal University, Jinan 250014, P. R. China

2. Department of Cancer Center, The Secondary Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, P. R. China

3. Laoshan Laboratory, 168 Wenhai Middle Rd, Aoshanwei Jimo, Qingdao 266237, P. R. China

Abstract

Novel Au–Se bond-based nanoprobes were designed for concurrent detection of PSA and PSMA in serum samples, aiming to enhance the early diagnosis of prostate cancer.

Funder

National Natural Science Foundation of China

Major Scientific and Technological Innovation Project of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/CC/D4CC00670D

Reference21 articles.

1. National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data

2. trans-Cleavage of the CRISPR-Cas12a-aptamer system for one-step antigen detection

3. Prostate cancer

4. Biosensors for detection of prostate cancer: a review

5. Magnetic Resonance Imaging of PSMA-Positive Prostate Cancer by a Targeted and Activatable Gd(III) MR Contrast Agent